Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glial Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06093165
What this trial is testing

RE-irradiation of Diffuse MIdline Glioma paTients

Who this might be right for
Diffuse Midline Glioma, H3 K27M-MutantDiffuse Intrinsic Pontine GliomaDiffuse Glioma+3 more
Rigshospitalet, Denmark 59
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Study completedNCT01158651
What this trial is testing

Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas

Who this might be right for
Glioma
University of Alabama at Birmingham 23
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Not applicableLooking for participantsNCT07450872
What this trial is testing

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

Who this might be right for
CancerGliomaLeukemia (Both ALL and AML)
The Children's Hospital of Zhejiang University School of Medicine 600
Not applicableStudy completedNCT02410577
What this trial is testing

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 2
Large-scale testing (Phase 3)Ended earlyNCT03393000
What this trial is testing

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Who this might be right for
Glioblastoma
Diffusion Pharmaceuticals Inc 19
Not applicableStudy completedNCT03926507
What this trial is testing

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01011231
What this trial is testing

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Who this might be right for
Glioblastoma
University of California, San Francisco 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06678867
What this trial is testing

The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours

Who this might be right for
Brain Tumor
University College, London 80
Not applicableEnrolling By InvitationNCT06814353
What this trial is testing

Intraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma

Who this might be right for
Medulloblastoma
Christian Dorfer 100
Early research (Phase 1)Ended earlyNCT00227032
What this trial is testing

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
UNC Lineberger Comprehensive Cancer Center 10
Early research (Phase 1)Active Not RecruitingNCT04606316
What this trial is testing

Surgical Nivolumab And Ipilimumab For Recurrent GBM

Who this might be right for
GlioblastomaGBMGlioblastoma Multiforme+1 more
Patrick Wen, MD 63
Testing effectiveness (Phase 2)UnknownNCT03650257
What this trial is testing

A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

Who this might be right for
Glioma of Brain
Cure&Sure Biotech Co., LTD 150
Early research (Phase 1)Study completedNCT01688401
What this trial is testing

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

Who this might be right for
Diffuse Intrinsic Pontine Glioma (DIPG)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)UnknownNCT00275067
What this trial is testing

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 50
Very early researchWithdrawnNCT04220892
What this trial is testing

Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

Who this might be right for
High Grade Glioma
Jose Carrillo
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Testing effectiveness (Phase 2)UnknownNCT04547621
What this trial is testing

HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Who this might be right for
Glioma, Malignant
Huashan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00003101
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 60
Next Page